APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rasagiline Mesylate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rasagiline Mesylate Tablets Market Outlook and Growth Opportunities 2026

19 December 2025199 pages

Choose your research edition.

Industry ResearchRasagiline Mesylate Tablets Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Rasagiline Mesylate Tablets Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Rasagiline Mesylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rasagiline Mesylate Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rasagiline Mesylate Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Rasagiline Mesylate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rasagiline Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rasagiline Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rasagiline Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rasagiline Mesylate Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rasagiline Mesylate Tablets market include Teva Pharmaceutical, Sun Pharmaceutical, Sandoz, Mylan, Takeda Pharmaceutical, Taj Pharma, Orchid Pharma, Natco Pharma and Lundbeck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rasagiline Mesylate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rasagiline Mesylate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rasagiline Mesylate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rasagiline Mesylate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Rasagiline Mesylate Tablets Segment by Company

Teva Pharmaceutical

Sun Pharmaceutical

Sandoz

Mylan

Takeda Pharmaceutical

Taj Pharma

Orchid Pharma

Natco Pharma

Lundbeck

Intas Pharmaceuticals

Apotex

Alkem Laboratories

Ajanta Pharma

Rasagiline Mesylate Tablets Segment by Type

0.5 mg/Pcs

1 mg/Pcs

Rasagiline Mesylate Tablets Segment by Application

40-65 Years Old

Under 40 Years Old

Above 65 Years Old

Rasagiline Mesylate Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Rasagiline Mesylate Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rasagiline Mesylate Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rasagiline Mesylate Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Rasagiline Mesylate Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rasagiline Mesylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rasagiline Mesylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rasagiline Mesylate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rasagiline Mesylate Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rasagiline Mesylate Tablets industry.

Chapter 3: Detailed analysis of Rasagiline Mesylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rasagiline Mesylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rasagiline Mesylate Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rasagiline Mesylate Tablets Industry Trends Table 2. Rasagiline Mesylate Tablets Industry Drivers Table 3. Rasagiline Mesylate Tablets Industry Opportunities and Challenges Table 4. Rasagiline Mesylate Tablets Industry Restraints Table 5. Global Rasagiline Mesylate Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rasagiline Mesylate Tablets Revenue Share by Company (2021-2026) Table 7. Global Rasagiline Mesylate Tablets Sales Volume by Company (W Pcs) & (2021-2026) Table 8. Global Rasagiline Mesylate Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Rasagiline Mesylate Tablets Average Price (US$/K Pcs) of Company (2021-2026) Table 10. Global Rasagiline Mesylate Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rasagiline Mesylate Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Rasagiline Mesylate Tablets Company, Product Type & Application Table 13. Global Rasagiline Mesylate Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rasagiline Mesylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.5 mg/Pcs Table 18. Significant Companies of 1 mg/Pcs Table 19. Global Rasagiline Mesylate Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (W Pcs) Table 20. Global Rasagiline Mesylate Tablets Sales Volume by Type (2021-2026) & (W Pcs) Table 21. Global Rasagiline Mesylate Tablets Sales Volume by Type (2027-2032) & (W Pcs) Table 22. Global Rasagiline Mesylate Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Rasagiline Mesylate Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Rasagiline Mesylate Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rasagiline Mesylate Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Rasagiline Mesylate Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Rasagiline Mesylate Tablets Sales Value Share by Type (2021-2026) Table 28. Global Rasagiline Mesylate Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of 40-65 Years Old Table 30. Significant Companies of Under 40 Years Old Table 31. Significant Companies of Above 65 Years Old Table 32. Global Rasagiline Mesylate Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (W Pcs) Table 33. Global Rasagiline Mesylate Tablets Sales Volume by Application (2021-2026) & (W Pcs) Table 34. Global Rasagiline Mesylate Tablets Sales Volume by Application (2027-2032) & (W Pcs) Table 35. Global Rasagiline Mesylate Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Rasagiline Mesylate Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Rasagiline Mesylate Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Rasagiline Mesylate Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Rasagiline Mesylate Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Rasagiline Mesylate Tablets Sales Value Share by Application (2021-2026) Table 41. Global Rasagiline Mesylate Tablets Sales Value Share by Application (2027-2032) Table 42. Global Rasagiline Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Table 43. Global Rasagiline Mesylate Tablets Sales by Region (2021-2026) & (W Pcs) Table 44. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2021-2026) Table 45. Global Rasagiline Mesylate Tablets Sales by Region (2027-2032) & (W Pcs) Table 46. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2027-2032) Table 47. Global Rasagiline Mesylate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Rasagiline Mesylate Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Rasagiline Mesylate Tablets Sales Value Share by Region (2021-2026) Table 50. Global Rasagiline Mesylate Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Rasagiline Mesylate Tablets Sales Value Share by Region (2027-2032) Table 52. Global Rasagiline Mesylate Tablets Market Average Price (US$/K Pcs) by Region (2021-2026) Table 53. Global Rasagiline Mesylate Tablets Market Average Price (US$/K Pcs) by Region (2027-2032) Table 54. Global Rasagiline Mesylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 55. Global Rasagiline Mesylate Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 57. Global Rasagiline Mesylate Tablets Sales Market Share by Country (2021-2026) Table 58. Global Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 59. Global Rasagiline Mesylate Tablets Sales Market Share by Country (2027-2032) Table 60. Global Rasagiline Mesylate Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Rasagiline Mesylate Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Rasagiline Mesylate Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Rasagiline Mesylate Tablets Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceutical Company Information Table 65. Teva Pharmaceutical Business Overview Table 66. Teva Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 68. Teva Pharmaceutical Recent Development Table 69. Sun Pharmaceutical Company Information Table 70. Sun Pharmaceutical Business Overview Table 71. Sun Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 72. Sun Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 73. Sun Pharmaceutical Recent Development Table 74. Sandoz Company Information Table 75. Sandoz Business Overview Table 76. Sandoz Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 77. Sandoz Rasagiline Mesylate Tablets Product Portfolio Table 78. Sandoz Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 82. Mylan Rasagiline Mesylate Tablets Product Portfolio Table 83. Mylan Recent Development Table 84. Takeda Pharmaceutical Company Information Table 85. Takeda Pharmaceutical Business Overview Table 86. Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 87. Takeda Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 88. Takeda Pharmaceutical Recent Development Table 89. Taj Pharma Company Information Table 90. Taj Pharma Business Overview Table 91. Taj Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 92. Taj Pharma Rasagiline Mesylate Tablets Product Portfolio Table 93. Taj Pharma Recent Development Table 94. Orchid Pharma Company Information Table 95. Orchid Pharma Business Overview Table 96. Orchid Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 97. Orchid Pharma Rasagiline Mesylate Tablets Product Portfolio Table 98. Orchid Pharma Recent Development Table 99. Natco Pharma Company Information Table 100. Natco Pharma Business Overview Table 101. Natco Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 102. Natco Pharma Rasagiline Mesylate Tablets Product Portfolio Table 103. Natco Pharma Recent Development Table 104. Lundbeck Company Information Table 105. Lundbeck Business Overview Table 106. Lundbeck Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 107. Lundbeck Rasagiline Mesylate Tablets Product Portfolio Table 108. Lundbeck Recent Development Table 109. Intas Pharmaceuticals Company Information Table 110. Intas Pharmaceuticals Business Overview Table 111. Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 112. Intas Pharmaceuticals Rasagiline Mesylate Tablets Product Portfolio Table 113. Intas Pharmaceuticals Recent Development Table 114. Apotex Company Information Table 115. Apotex Business Overview Table 116. Apotex Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 117. Apotex Rasagiline Mesylate Tablets Product Portfolio Table 118. Apotex Recent Development Table 119. Alkem Laboratories Company Information Table 120. Alkem Laboratories Business Overview Table 121. Alkem Laboratories Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 122. Alkem Laboratories Rasagiline Mesylate Tablets Product Portfolio Table 123. Alkem Laboratories Recent Development Table 124. Ajanta Pharma Company Information Table 125. Ajanta Pharma Business Overview Table 126. Ajanta Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Value (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 127. Ajanta Pharma Rasagiline Mesylate Tablets Product Portfolio Table 128. Ajanta Pharma Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Rasagiline Mesylate Tablets Distributors List Table 132. Rasagiline Mesylate Tablets Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Rasagiline Mesylate Tablets Product Image Figure 2. Global Rasagiline Mesylate Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rasagiline Mesylate Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rasagiline Mesylate Tablets Sales (2021-2032) & (W Pcs) Figure 5. Global Rasagiline Mesylate Tablets Sales Average Price (US$/K Pcs) & (2021-2032) Figure 6. Global Rasagiline Mesylate Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.5 mg/Pcs Image Figure 10. 1 mg/Pcs Image Figure 11. Global Rasagiline Mesylate Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 12. Global Rasagiline Mesylate Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Rasagiline Mesylate Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Rasagiline Mesylate Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Rasagiline Mesylate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Rasagiline Mesylate Tablets Sales Value Share by Type (2021-2032) Figure 17. 40-65 Years Old Image Figure 18. Under 40 Years Old Image Figure 19. Above 65 Years Old Image Figure 20. Global Rasagiline Mesylate Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 21. Global Rasagiline Mesylate Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Rasagiline Mesylate Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Rasagiline Mesylate Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Rasagiline Mesylate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Rasagiline Mesylate Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Rasagiline Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Figure 27. Global Rasagiline Mesylate Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Rasagiline Mesylate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Rasagiline Mesylate Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Rasagiline Mesylate Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Rasagiline Mesylate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Rasagiline Mesylate Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Rasagiline Mesylate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Rasagiline Mesylate Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Rasagiline Mesylate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Rasagiline Mesylate Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Rasagiline Mesylate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Rasagiline Mesylate Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Rasagiline Mesylate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Rasagiline Mesylate Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Rasagiline Mesylate Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5 mg/Pcs
  • 1 mg/Pcs
Applications
  • 40-65 Years Old
  • Under 40 Years Old
  • Above 65 Years Old
Companies covered
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Takeda Pharmaceutical
  • Taj Pharma
  • Orchid Pharma
  • Natco Pharma
  • Lundbeck
  • Intas Pharmaceuticals
  • Apotex
  • Alkem Laboratories
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rasagiline Mesylate Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Rasagiline Mesylate Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Rasagiline Mesylate Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rasagiline Mesylate Tablets Market Dynamics
  1. 2.1 Rasagiline Mesylate Tablets Industry Trends
  2. 2.2 Rasagiline Mesylate Tablets Industry Drivers
  3. 2.3 Rasagiline Mesylate Tablets Industry Opportunities and Challenges
  4. 2.4 Rasagiline Mesylate Tablets Industry Restraints
3 Rasagiline Mesylate Tablets Market by Company
  1. 3.1 Global Rasagiline Mesylate Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Rasagiline Mesylate Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Rasagiline Mesylate Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Rasagiline Mesylate Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Rasagiline Mesylate Tablets Company Ranking (2024-2026)
  6. 3.6 Global Rasagiline Mesylate Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Rasagiline Mesylate Tablets Company Product Type and Application
  8. 3.8 Global Rasagiline Mesylate Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rasagiline Mesylate Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rasagiline Mesylate Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rasagiline Mesylate Tablets Market by Type
  1. 4.1 Rasagiline Mesylate Tablets Type Introduction
  2. 4.1.1 0.5 mg/Pcs
  3. 4.1.2 1 mg/Pcs
  4. 4.2 Global Rasagiline Mesylate Tablets Sales Volume by Type
  5. 4.2.1 Global Rasagiline Mesylate Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rasagiline Mesylate Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Rasagiline Mesylate Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Rasagiline Mesylate Tablets Sales Value by Type
  9. 4.3.1 Global Rasagiline Mesylate Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rasagiline Mesylate Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Rasagiline Mesylate Tablets Sales Value Share by Type (2021-2032)
5 Rasagiline Mesylate Tablets Market by Application
  1. 5.1 Rasagiline Mesylate Tablets Application Introduction
  2. 5.1.1 40-65 Years Old
  3. 5.1.2 Under 40 Years Old
  4. 5.1.3 Above 65 Years Old
  5. 5.2 Global Rasagiline Mesylate Tablets Sales Volume by Application
  6. 5.2.1 Global Rasagiline Mesylate Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rasagiline Mesylate Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rasagiline Mesylate Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rasagiline Mesylate Tablets Sales Value by Application
  10. 5.3.1 Global Rasagiline Mesylate Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rasagiline Mesylate Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rasagiline Mesylate Tablets Sales Value Share by Application (2021-2032)
6 Rasagiline Mesylate Tablets Regional Sales and Value Analysis
  1. 6.1 Global Rasagiline Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rasagiline Mesylate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Rasagiline Mesylate Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Rasagiline Mesylate Tablets Sales by Region (2027-2032)
  5. 6.3 Global Rasagiline Mesylate Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rasagiline Mesylate Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rasagiline Mesylate Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rasagiline Mesylate Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Rasagiline Mesylate Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rasagiline Mesylate Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Rasagiline Mesylate Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rasagiline Mesylate Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Rasagiline Mesylate Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rasagiline Mesylate Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rasagiline Mesylate Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rasagiline Mesylate Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Rasagiline Mesylate Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rasagiline Mesylate Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rasagiline Mesylate Tablets Sales Value Share by Country, 2025 VS 2032
7 Rasagiline Mesylate Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Rasagiline Mesylate Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rasagiline Mesylate Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rasagiline Mesylate Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Rasagiline Mesylate Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Rasagiline Mesylate Tablets Sales by Country (2027-2032)
  6. 7.4 Global Rasagiline Mesylate Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rasagiline Mesylate Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rasagiline Mesylate Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rasagiline Mesylate Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rasagiline Mesylate Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rasagiline Mesylate Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Rasagiline Mesylate Tablets Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Rasagiline Mesylate Tablets Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Takeda Pharmaceutical
  26. 8.5.1 Takeda Pharmaceutical Company Information
  27. 8.5.2 Takeda Pharmaceutical Business Overview
  28. 8.5.3 Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Takeda Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  30. 8.5.5 Takeda Pharmaceutical Recent Developments
  31. 8.6 Taj Pharma
  32. 8.6.1 Taj Pharma Company Information
  33. 8.6.2 Taj Pharma Business Overview
  34. 8.6.3 Taj Pharma Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharma Rasagiline Mesylate Tablets Product Portfolio
  36. 8.6.5 Taj Pharma Recent Developments
  37. 8.7 Orchid Pharma
  38. 8.7.1 Orchid Pharma Company Information
  39. 8.7.2 Orchid Pharma Business Overview
  40. 8.7.3 Orchid Pharma Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Orchid Pharma Rasagiline Mesylate Tablets Product Portfolio
  42. 8.7.5 Orchid Pharma Recent Developments
  43. 8.8 Natco Pharma
  44. 8.8.1 Natco Pharma Company Information
  45. 8.8.2 Natco Pharma Business Overview
  46. 8.8.3 Natco Pharma Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Natco Pharma Rasagiline Mesylate Tablets Product Portfolio
  48. 8.8.5 Natco Pharma Recent Developments
  49. 8.9 Lundbeck
  50. 8.9.1 Lundbeck Company Information
  51. 8.9.2 Lundbeck Business Overview
  52. 8.9.3 Lundbeck Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lundbeck Rasagiline Mesylate Tablets Product Portfolio
  54. 8.9.5 Lundbeck Recent Developments
  55. 8.10 Intas Pharmaceuticals
  56. 8.10.1 Intas Pharmaceuticals Company Information
  57. 8.10.2 Intas Pharmaceuticals Business Overview
  58. 8.10.3 Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Intas Pharmaceuticals Rasagiline Mesylate Tablets Product Portfolio
  60. 8.10.5 Intas Pharmaceuticals Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Rasagiline Mesylate Tablets Product Portfolio
  66. 8.11.5 Apotex Recent Developments
  67. 8.12 Alkem Laboratories
  68. 8.12.1 Alkem Laboratories Company Information
  69. 8.12.2 Alkem Laboratories Business Overview
  70. 8.12.3 Alkem Laboratories Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Alkem Laboratories Rasagiline Mesylate Tablets Product Portfolio
  72. 8.12.5 Alkem Laboratories Recent Developments
  73. 8.13 Ajanta Pharma
  74. 8.13.1 Ajanta Pharma Company Information
  75. 8.13.2 Ajanta Pharma Business Overview
  76. 8.13.3 Ajanta Pharma Rasagiline Mesylate Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ajanta Pharma Rasagiline Mesylate Tablets Product Portfolio
  78. 8.13.5 Ajanta Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rasagiline Mesylate Tablets Value Chain Analysis
  2. 9.1.1 Rasagiline Mesylate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rasagiline Mesylate Tablets Sales Mode & Process
  6. 9.2 Rasagiline Mesylate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rasagiline Mesylate Tablets Distributors
  9. 9.2.3 Rasagiline Mesylate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst